68Ga-PSMA-11 PET/CT demonstrated nearly 3 times higher sensitivity for seminal vesicle invasion (85.1% vs. 29.4%) and almost 4 times higher sensitivity for lymph node metastases (87.5% vs. 23.1%) than did MRI (Figs. 1 and 2). Here, FOLH1 is linked to metastatic malignant neoplasm in the lymph nodes.